Relating to drugs; and prescribing an effective date.
Catchline/Summary:
Removes special training requirement from statutes governing prescribing, dispensing and distributing naloxone. Removes special training requirement from statutes governing prescribing, dispensing and distributing naloxone.
Specifies that reimbursing cost of medication prescribed for purpose of treating opioid or opiate withdrawal does not require prior authorization during first 30 days of treatment.
Specifies that individual may not be denied entry into specialty court in this state solely for reason that individual is taking, or intends to take, medication prescribed by licensed health care practitioner for treatment of drug abuse or dependency.
Requires Oregon Health Authority to publish and report information related to opioids and opiates.
Requires pharmacy to report deidentified information to prescription monitoring program upon dispensing prescribed naloxone.
Requires pharmacy to report certain other identifying information to prescription monitoring program upon dispensing prescribed controlled substance classified in schedules II through IV.
Requires information to be disclosed from prescription monitoring program to medical director or pharmacy director. Requires information to be disclosed from prescription monitoring program for certain other purposes.
Requires licensing information of licensees who are authorized to prescribe or dispense controlled substances to be provided to authority for purpose of qualifying licensees to report information to, or receive information from, prescription monitoring program.
Specifies that authority may require person requesting deidentified information from prescription monitoring program to enter into data use agreement with authority.
Requires authority, not less than once per year, to develop, through use of prescription monitoring information, criteria by which practitioner may be required to receive education or training on prescribing of opioids or opiates. Creates Prescription Monitoring Program Prescribing Practices Review Subcommittee for purposes of advising authority on development of criteria, reviewing practitioner's history to determine whether practitioner meets criteria and directing authority to provide educational material to practitioner who meets criteria.
Provides that authority may enter into agreements governing sharing and use of information reported to prescription monitoring program with regulatory authorities of other states that administer prescription monitoring programs.
Provides that prescription monitoring program provisions become operative January 1, 2018.
Takes effect on 91st day following adjournment sine die.
Oregon Legislative Assembly - Public Testimony Registration Form
You are registering to speak about:
HB 3440
Registration Instructions
Submit the form below to testify or comment either in person or remotely by video or phone. After completing the required fields (*), click the “Submit Registration to Testify” button.
Email address and phone number are required for administrative purposes and will not be posted to OLIS. Your phone number will be displayed on the livestream of the committee meeting if you testify by phone.
Registration ends 30 minutes prior to the start of the meeting. After that time, the registration system will close.
After registering and seeing a confirmation screen, you will receive an email with meeting details. If you do not receive a confirmation email, check your email spam folder.
Registration does not guarantee that you will have an opportunity to speak; the chair may determine that time for public testimony will be limited. Committee meetings are sometimes cancelled or rescheduled. You can receive email updates on selected bills or committee agendas by signing up for Capitol e-Subscribe.
If you would like to provide written testimony to the committee, see instructions to submit written testimony here.
To request spoken language interpretation, American Sign Language (ASL) interpretation, or Communication Access Realtime Translation (CART) services, please email languageaccess@oregonlegislature.gov or call 503-986-1538 at least 3 days in advance.
Para solicitar servicios de interpretación de lenguaje hablado, interpretación de lenguaje de señas americano (ASL) o traducción en tiempo real de acceso a la comunicación (CART), envíe un correo electrónico a languageaccess@oregonlegislature.gov o llame al 503-986-1538 con 3 dias de anticipación.
Confidential - Administrative Use Only
Will you travel more than 100 miles to this meeting to testify?
You Have Successfully Registered to Testify
Testimony Details:
You will receive an email soon with meeting details. If you registered to testify remotely, the
email will include a link or phone number to join the committee meeting.
If you do not receive a confirmation within 24 hours, have any questions, or need to cancel your registration,
please call 1-833-588-4500 or email the committee assistant listed on the committee page on OLIS.
Committee meetings are sometimes canceled or rescheduled. If you register to testify and the meeting is
rescheduled, you will need to register for the new meeting date. To receive email updates on selected
bills or committee agendas, sign up for Capitol E-Subscribe.
Measure Not Scheduled for Public Testimony
Thank you for your interest in providing public testimony on measure .
Either this measure is not currently scheduled for a public hearing, or the deadline to register to testify
or to submit written testimony has passed.
For questions about the legislature, legislative process, or other government agencies, please email
help.leg@oregonlegislature.gov or call 1-800-332-2313.
Measure Not Scheduled for Public Testimony
Thank you for your interest in providing written testimony on measure .
Either this measure is not currently scheduled for a public hearing, or the deadline to register to testify
or to submit written testimony has passed.
For questions about the legislature, legislative process, or other government agencies, please email
help.leg@oregonlegislature.gov or call 1-800-332-2313.